Connective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017Patient & Survivor CareAggressive Lymphomas
Adding rituximab to reduced intensity conditioning boosts PFSMarch 2, 2017Aggressive LymphomasCellular Therapy
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaT Cell LymphomasMantle Cell LymphomaIndolent LymphomaAggressive Lymphomas
Neuropathic pain puts cancer survivors out of workFebruary 5, 2017Patient & Survivor CareT Cell LymphomasAggressive Lymphomas
Long view shows doubling of survival in non-Hodgkin lymphomaJanuary 30, 2017Aggressive LymphomasIndolent LymphomaHodgkin Lymphoma
Hodgkin lymphoma survival has nearly tripled since the 1950sJanuary 30, 2017Indolent LymphomaAggressive LymphomasHodgkin Lymphoma
VIDEO: First multicenter trial of CAR T cells shows response in DLBCLJanuary 19, 2017Mantle Cell LymphomaAggressive Lymphomas
Worse outcomes for double-hit lymphomas after ASCTNovember 23, 2016Aggressive LymphomasCellular Therapy
Hepatitis infection raises non-Hodgkin lymphoma risk in HIV patientsOctober 17, 2016Aggressive LymphomasHodgkin Lymphoma
Is stem-cell transplant curative for HIV infection?August 29, 2016Aggressive LymphomasTransfusion Medicine
Treatment may allow HSCT without radiation, chemotherapyAugust 27, 2016Multiple MyelomaAggressive LymphomasALLAML
